BBT-176, a Novel Fourth-Generation Tyrosine Kinase Inhibitor for Osimertinib-Resistant EGFR Mutations in Non–Small Cell Lung CancerSun Min Lim, Sang-Yoon Lee|Clinical Cancer Research|2023Cited by 72